NASDAQ
14.07.26 | 21:59
7,050 US-Dollar
-0,70 % -0,050
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.06. | Profound Medical Corp. (PROF) Dropped Despite High Potential | 1 | Insider Monkey | ||
| 18.05. | Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High? | 15 | Zacks | ||
| 15.05. | Profound Medical Corp (2): Profound, Telix form partnership on prostate imaging | 4 | Stockwatch | ||
| 14.05. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Profound Medical Corp.: Profound Medical Annual General and Special Meeting of Shareholders Voting Results | 546 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General... ► Artikel lesen | |
| 07.05. | Profound Medical Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 17.04. | Profound Medical Corp (2): Profound to release Q1 results, host call May 7 | 1 | Stockwatch | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 14.04. | Stocks in Play: Profound Medical Corp. | 1 | Baystreet.ca | ||
| 14.04. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 01.04. | Profound Medical Corp.: Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting | 1 | GlobeNewswire (USA) | ||
| 27.03. | Profound Medical Corp (2): Profound talks up Tulsa procedure milestone in Texas | 3 | Stockwatch | ||
| 27.03. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.03. | Profound Medical Corp.: Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone | 2 | GlobeNewswire (USA) | ||
| 16.03. | Profound Medical: Raymond James bestätigt "Outperform"-Rating nach starken Studiendaten | 2 | Investing.com Deutsch | ||
| 16.03. | Profound Medical stock rating reiterated by Raymond James on trial data | 2 | Investing.com | ||
| 13.03. | Profound Medical Corp.: CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence | 2 | GlobeNewswire (USA) | ||
| 13.03. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Profound Medical Corp (2): Profound to discuss Captain trial results March 13 | 14 | Stockwatch | ||
| 06.03. | Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026 | 6 | Seeking Alpha |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 3,650 | +2,38 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide in Leptomeningeal Metastases Monitoring | HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), today highlighted the recent update to the National Comprehensive Cancer Network (NCCN)... ► Artikel lesen | |
| ORGANON | 11,780 | -0,30 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| QUIDELORTHO | 15,540 | +0,52 % | QuidelOrtho Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| NANO-X IMAGING | 1,065 | +0,47 % | NANO-X IMAGING LTD: New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026 | New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its... ► Artikel lesen | |
| ROCKWELL MEDICAL | 5,630 | 0,00 % | H.C. Wainwright hebt Kursziel für Rockwell Medical Aktie auf 20 $ an | ||
| NUWELLIS, INC | 3,220 | 0,00 % | XFRA 22S1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUWELL.INC.NEW26... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| NEURONETICS | 1,515 | -2,57 % | Neuronetics Appoints Robert Greene as Senior Vice President Sales | MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| PULSE BIOSCIENCES | 22,000 | -0,90 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| OPTIMIZERX | 6,530 | 0,00 % | OptimizeRx Corporation: OptimizeRx Launches CopayCue, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent | WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 10,100 | 0,00 % | CMS-Kehrtwende bei Kostenerstattung: Canaccord bestätigt "Buy"-Rating für Orthofix Medical | ||
| PAVMED | 4,760 | +3,14 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| OWLET | 6,445 | +0,55 % | Owlet Announces New $25 Million Credit Facility With Wells Fargo | ||
| PICARD MEDICAL | 0,148 | 0,00 % | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | ||
| QTREX QUANTUM | 1,495 | -0,33 % | QTREX secures commercial order for shielded RF monolithic components |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 7,050 Euro und damit -0,70 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.